TICKER INTELLIGENCE
$PHG is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $PHG, including 1 bill. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
$PHG is currently facing 1 active congressional signal tracked by HillSignal. With 0 bullish, 1 neutral, and 0 bearish signal, the average legislative impact score is 4.0/10. Key sectors affected include Healthcare. Recent major catalysts include Lung Cancer Screening and Prevention Act of 2025. Below is the complete tracker of government activity affecting $PHG’s market performance.
1
Total Signals
4.0/10
Avg Impact
0
Bullish Signals
0
Bearish Signals
The Lung Cancer Screening and Prevention Act of 2025 (HR1406) is in the early stages of the legislative process, having been referred to two committees. This bill would expand Medicare coverage for FDA-approved lung cancer screening tests, potentially increasing the total addressable market for diagnostic imaging and testing companies. No specific funding amount is authorized, with coverage and payment limits to be determined by the Secretary.
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →